Skip to main content
. 2023 May 18;261(11):3299–3306. doi: 10.1007/s00417-023-06108-y

Fig. 1.

Fig. 1

Countries that allow intravitreal anti-VEGF administration either outside the hospital (dotted) or exclusively within hospital settings or analogous healthcare facilities (black)